Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 30-Sep 2021. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4592031012 | Amivantamab-containing product in parenteral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4592032017 | Product containing amivantamab in parenteral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 1026931000241116 | médicament contenant amivantamab, forme parentérale | fr | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Switzerland NRC maintained Module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Amivantamab-containing product in parenteral dose form | Is a | Amivantamab-containing product | true | Inferred relationship | Some | ||
| Amivantamab-containing product in parenteral dose form | Is a | Product manufactured as parenteral dose form (product) | true | Inferred relationship | Some | ||
| Amivantamab-containing product in parenteral dose form | Has manufactured dose form | Parenteral dose form (dose form) | true | Inferred relationship | Some | ||
| Amivantamab-containing product in parenteral dose form | Plays role | Antineoplastic therapeutic role | true | Inferred relationship | Some | ||
| Amivantamab-containing product in parenteral dose form | Has active ingredient | Amivantamab (substance) | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing only amivantamab in parenteral dose form (medicinal product form) | Is a | True | Amivantamab-containing product in parenteral dose form | Inferred relationship | Some |
This concept is not in any reference sets
FHIR